Stockscreener 앱 받기
83.67
1.48%
1.185
전일 마감가:
$82.49
열려 있는:
$82.7
하루 거래량:
8.10M
Relative Volume:
0.70
시가총액:
$208.91B
수익:
$63.99B
순이익/손실:
$19.05B
주가수익비율:
11.07
EPS:
7.5596
순현금흐름:
$14.72B
1주 성능:
-3.81%
1개월 성능:
-6.14%
6개월 성능:
+0.64%
1년 성능:
-17.83%
1일 변동 폭
$82.01
$84.96
1주일 범위
$82.01
$87.84
52주 변동 폭
$73.31
$105.07
머크앤드컴퍼니 Stock (MRK) Company Profile
명칭
Merck Co Inc
전화
908-740-4000
주소
126 EAST LINCOLN AVENUE, RAHWAY, NJ
MRK을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
MRK
Merck Co Inc
|
83.64 | 206.04B | 63.99B | 19.05B | 14.72B | 7.5596 |
|
LLY
Lilly Eli Co
|
902.94 | 802.41B | 59.42B | 18.41B | 6.44B | 20.22 |
|
JNJ
Johnson Johnson
|
186.79 | 448.76B | 92.15B | 25.12B | 20.46B | 10.36 |
|
ABBV
Abbvie Inc
|
216.90 | 374.44B | 59.64B | 2.37B | 18.24B | 1.331 |
|
NVS
Novartis Ag Adr
|
124.94 | 237.66B | 54.45B | 14.42B | 17.15B | 7.333 |
머크앤드컴퍼니 Stock (MRK) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-10-13 | 재개 | Citigroup | Neutral |
| 2025-09-17 | 다운그레이드 | Berenberg | Buy → Hold |
| 2025-05-14 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2025-04-22 | 개시 | Cantor Fitzgerald | Neutral |
| 2025-02-18 | 다운그레이드 | Deutsche Bank | Buy → Hold |
| 2025-02-10 | 다운그레이드 | TD Cowen | Buy → Hold |
| 2025-01-08 | 다운그레이드 | Truist | Buy → Hold |
| 2024-12-20 | 다운그레이드 | BMO Capital Markets | Outperform → Market Perform |
| 2024-12-10 | 재개 | BofA Securities | Buy |
| 2024-12-04 | 업그레이드 | HSBC Securities | Hold → Buy |
| 2024-11-15 | 개시 | Wolfe Research | Peer Perform |
| 2024-11-11 | 다운그레이드 | Daiwa Securities | Buy → Neutral |
| 2024-10-17 | 개시 | Bernstein | Mkt Perform |
| 2024-03-11 | 다운그레이드 | Societe Generale | Hold → Sell |
| 2024-01-04 | 업그레이드 | TD Cowen | Market Perform → Outperform |
| 2023-11-09 | 개시 | Deutsche Bank | Buy |
| 2023-10-27 | 업그레이드 | BMO Capital Markets | Market Perform → Outperform |
| 2023-10-20 | 업그레이드 | UBS | Neutral → Buy |
| 2023-07-14 | 개시 | HSBC Securities | Hold |
| 2023-04-13 | 업그레이드 | Citigroup | Neutral → Buy |
| 2023-03-28 | 다운그레이드 | Societe Generale | Buy → Hold |
| 2023-03-13 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2023-03-06 | 개시 | Jefferies | Buy |
| 2023-02-22 | 업그레이드 | Wolfe Research | Peer Perform → Outperform |
| 2023-01-04 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2022-11-18 | 개시 | Credit Suisse | Outperform |
| 2022-10-10 | 업그레이드 | Guggenheim | Neutral → Buy |
| 2022-09-14 | 업그레이드 | Berenberg | Hold → Buy |
| 2022-07-06 | 업그레이드 | Daiwa Securities | Neutral → Buy |
| 2022-06-06 | 재개 | SVB Leerink | Outperform |
| 2022-04-06 | 재개 | Morgan Stanley | Equal-Weight |
| 2021-12-17 | 개시 | Goldman | Buy |
| 2021-12-16 | 개시 | Daiwa Securities | Neutral |
| 2021-12-13 | 다운그레이드 | UBS | Buy → Neutral |
| 2021-12-09 | 개시 | Wells Fargo | Overweight |
| 2021-12-07 | 다운그레이드 | Guggenheim | Buy → Neutral |
| 2021-11-29 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2021-11-19 | 개시 | BMO Capital Markets | Market Perform |
| 2021-11-01 | 업그레이드 | Argus | Hold → Buy |
| 2021-09-07 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2021-07-27 | 재개 | Truist | Buy |
| 2021-05-20 | 다운그레이드 | Argus | Buy → Hold |
| 2021-04-07 | 재개 | RBC Capital Mkts | Sector Perform |
| 2020-11-10 | 재개 | Bernstein | Outperform |
| 2020-09-29 | 개시 | Berenberg | Hold |
| 2020-08-03 | 업그레이드 | Goldman | Neutral → Buy |
| 2020-06-12 | 다운그레이드 | Wolfe Research | Outperform → Peer Perform |
| 2020-02-27 | 개시 | Barclays | Overweight |
| 2020-01-07 | 개시 | RBC Capital Mkts | Sector Perform |
| 2019-10-17 | 재개 | BofA/Merrill | Neutral |
| 2019-08-16 | 개시 | SVB Leerink | Outperform |
| 2019-07-03 | 개시 | Mizuho | Buy |
| 2019-05-28 | 개시 | Goldman | Neutral |
| 2019-05-13 | 업그레이드 | Atlantic Equities | Neutral → Overweight |
| 2018-10-16 | 재확인 | Citigroup | Buy |
| 2018-10-09 | 재개 | Guggenheim | Buy |
| 2018-04-23 | 업그레이드 | Goldman | Neutral → Buy |
| 2018-04-17 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2018-04-05 | 업그레이드 | Barclays | Equal Weight → Overweight |
| 2018-03-12 | 업그레이드 | Leerink Partners | Mkt Perform → Outperform |
| 2018-02-14 | 재확인 | Leerink Partners | Mkt Perform |
| 2018-02-07 | 재확인 | Morgan Stanley | Equal-Weight |
| 2018-01-16 | 업그레이드 | SunTrust | Hold → Buy |
모두보기
머크앤드컴퍼니 주식(MRK)의 최신 뉴스
Merck secures $700 million funding from Blackstone to develop cancer therapy - Reuters
Merck inks $700M deal with Blackstone for cancer drug (MRK) - Seeking Alpha
NewSquare Capital LLC Has $5.16 Million Stock Position in Merck & Co., Inc. $MRK - MarketBeat
Tufton Capital Management Decreases Stock Holdings in Merck & Co., Inc. $MRK - MarketBeat
McGinn Penninger Investment Management Inc. Buys 11,666 Shares of Merck & Co., Inc. $MRK - MarketBeat
Prosperity Consulting Group LLC Sells 3,220 Shares of Merck & Co., Inc. $MRK - MarketBeat
Merck Enters into Research and Development Funding Agreement with Blackstone Life Sciences for Sacituzumab Tirumotecan (sac-TMT) - Business Wire
Merck Signs Agreement with Dr. Falk Pharma GmbH for Certain Development and Commercialization Rights to MK-8690 (PRA-052) an Investigational Anti-CD30 Ligand Monoclonal Antibody - Business Wire
Northcape Wealth Management LLC Sells 18,750 Shares of Merck & Co., Inc. $MRK - MarketBeat
Roffman Miller Associates Inc. PA Increases Stock Holdings in Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. $MRK Shares Sold by Burney Co. - MarketBeat
Intellectus Partners LLC Has $698,000 Stock Position in Merck & Co., Inc. $MRK - MarketBeat
Should You Buy the 3 Highest-Paying Dividend Stocks in the Dow Jones? - The Motley Fool
Merck & Co (MRK) Analyst Rating Update by Morgan Stanley | MRK S - GuruFocus
Merck & Co., Inc. (NYSE:MRK) Given New $100.00 Price Target at Morgan Stanley - MarketBeat
Merck & Co. Inc. (MRK) Reports Solid Q3 with Strong Drug Sales and Pipeline Progress - MSN
Obermeyer Wealth Partners Sells 151,400 Shares of Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. $MRK Stock Holdings Lessened by Bank of New York Mellon Corp - MarketBeat
Freestone Capital Holdings LLC Boosts Holdings in Merck & Co., Inc. $MRK - MarketBeat
K.J. Harrison & Partners Inc Invests $645,000 in Merck & Co., Inc. $MRK - MarketBeat
Are Wall Street Analysts Predicting Merck & Co. Stock Will Climb or Sink? - Barchart.com
TIAA Trust National Association Sells 43,141 Shares of Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. $MRK Shares Bought by iA Global Asset Management Inc. - MarketBeat
Animal Vaccines Market Huge Growth and Future Scope 2025 -2032| - openPR.com
Merck & Co., Inc. Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next - simplywall.st
Results: Merck & Co., Inc. Beat Earnings Expectations And Analysts Now Have New Forecasts - Yahoo Finance
State of Michigan Retirement System Has $58.98 Million Stock Position in Merck & Co., Inc. $MRK - MarketBeat
Nicholas Company Inc. Sells 599,266 Shares of Merck & Co., Inc. $MRK - MarketBeat
Tredje AP fonden Sells 347,631 Shares of Merck & Co., Inc. $MRK - MarketBeat
SS&H Financial Advisors Inc. Increases Holdings in Merck & Co., Inc. $MRK - MarketBeat
Welch & Forbes LLC Sells 5,950 Shares of Merck & Co., Inc. $MRK - MarketBeat
GHP Investment Advisors Inc. Decreases Stake in Merck & Co., Inc. $MRK - MarketBeat
Plato Investment Management Ltd Has $4.98 Million Stock Holdings in Merck & Co., Inc. $MRK - MarketBeat
Integrity Alliance LLC. Decreases Position in Merck & Co., Inc. $MRK - MarketBeat
Assetmark Inc. Sells 3,278 Shares of Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. (NYSE:MRK) Q3 2025 Earnings Call Transcript - Insider Monkey
Merck & Co., Inc. $MRK Position Cut by ANTIPODES PARTNERS Ltd - MarketBeat
Atlas Private Wealth Advisors Trims Stake in Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. $MRK Shares Bought by Lifeworks Advisors LLC - MarketBeat
Center for Financial Planning Inc. Sells 3,779 Shares of Merck & Co., Inc. $MRK - MarketBeat
Syverson Strege & Co Acquires Shares of 4,356 Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. $MRK Shares Sold by AMG National Trust Bank - MarketBeat
Merck & Co., Inc. $MRK Shares Bought by IFG Advisory LLC - MarketBeat
Merck & Co., Inc. $MRK Shares Sold by AlphaQuest LLC - MarketBeat
Morgan Stanley Adjusts Price Target on Merck & Co. to $100 From $98 - MarketScreener
Merck & Company, Inc. (MRK) Stock Forecasts - Yahoo! Finance Canada
Goldman Sachs Adjusts Price Target on Merck & Co to $92 From $93 - MarketScreener
Fisher Funds Management LTD Sells 21,137 Shares of Merck & Co., Inc. $MRK - MarketBeat
Canton Hathaway LLC Lowers Position in Merck & Co., Inc. $MRK - MarketBeat
136,100 Shares in Merck & Co., Inc. $MRK Purchased by Lockheed Martin Investment Management Co. - MarketBeat
Merck & Co., Inc. $MRK Shares Purchased by Amplius Wealth Advisors LLC - MarketBeat
머크앤드컴퍼니 (MRK) 재무 분석
매출
순이익
현금흐름
주당 순 이익
2.06%
0.35%
자본화:
|
볼륨(24시간):